# SpyBiotech

**Canonical:** https://apis.io/providers/spybiotech/  
**Website:** https://spybiotech.com  
**APIs profiled:** 0

SpyBiotech is a clinical-stage biotechnology company developing next-generation vaccines against infectious diseases and cancer using its proprietary SpyTag/SpyCatcher "protein superglue" platform. The technology snaps target antigens onto virus-like particles (VLPs) to produce highly immunogenic vaccines with greater ease and speed. An Oxford University spinout backed by GV, its pipeline includes candidates such as SpyVLP01 targeting human cytomegalovirus (hCMV). This is a company profile in the API Evangelist network; SpyBiotech publishes a corporate marketing website but no public developer or product API surface.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Spybiotech Domain Security** — TLSv1.3

## Tags

Company, Life Sciences, Biotechnology, Vaccines, Immunology, Pharmaceuticals, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/spybiotech/). Scores are computed from the provider's own public artifacts under a published rubric.